沪深市场个股详情
688098 申联生物
- 5.62
- +0.15+2.74%
午间休市 11/29 11:29 (北京)
23.08亿总市值-117083市盈率TTM
5.63最高价5.44最低价2.10万手成交量5.44今开5.47昨收1165.33万成交额0.51%换手率72.99市盈率(静)4.11亿总股本7.9252周最高1.58市净率23.08亿流通值3.6352周最低6.56涨停价4.11亿流通股36.50历史最高4.38跌停价3.47%振幅3.63历史最低0.04股息TTM5.55平均价8608.89手内盘0.62%股息率TTM100股每手1.21万手外盘
申联生物关键统计数据
全部
显示同比
| (Q9)2024/09/30 | (Q6)2024/06/30 | (Q3)2024/03/31 | (FY)2023/12/31 | (Q9)2023/09/30 | (Q6)2023/06/30 | (Q3)2023/03/31 | (FY)2022/12/31 | (Q9)2022/09/30 | (Q6)2022/06/30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 营业总收入 | 3.71%2.48亿 | 2.68%1.26亿 | 7.58%8,805.82万 | -8.25%3.01亿 | -16.46%2.39亿 | -10.99%1.23亿 | -8.08%8,185.18万 | -8.32%3.29亿 | 5.20%2.87亿 | -9.65%1.38亿 |
| 营业收入 | 3.71%2.48亿 | 2.68%1.26亿 | 7.58%8,805.82万 | -8.25%3.01亿 | -16.46%2.39亿 | -10.99%1.23亿 | -8.08%8,185.18万 | -8.32%3.29亿 | 5.20%2.87亿 | -9.65%1.38亿 |
| 营业总成本 | 30.56%2.59亿 | 40.30%1.63亿 | 40.36%8,981.77万 | 7.58%2.71亿 | -1.12%1.99亿 | 2.74%1.16亿 | 0.08%6,399.28万 | 2.75%2.52亿 | 14.34%2.01亿 | 3.25%1.13亿 |
| 营业成本 | 44.56%9,655.04万 | 45.32%5,257.49万 | 52.24%3,432.23万 | 8.03%8,793.4万 | -4.38%6,679万 | 0.42%3,617.79万 | -4.05%2,254.44万 | -6.43%8,139.56万 | 17.03%6,985.11万 | 28.66%3,602.65万 |
| 营业税金及附加 | -0.67%332.13万 | -5.65%206.92万 | 12.14%110.9万 | 28.63%441.15万 | 34.80%334.36万 | 44.26%219.31万 | 6.34%98.89万 | -3.80%342.97万 | -3.21%248.03万 | -1.98%152.02万 |
| 销售费用 | 27.48%7,722.55万 | 55.28%5,335.55万 | 38.29%2,547.41万 | 15.41%8,438.56万 | 13.68%6,057.81万 | 0.50%3,436.01万 | -13.32%1,842.02万 | 15.37%7,311.63万 | 20.76%5,328.91万 | 9.43%3,418.88万 |
| 管理费用 | 17.44%4,499.53万 | 19.36%2,956.19万 | 21.80%1,637.21万 | -9.43%5,033.01万 | -22.69%3,831.45万 | -2.99%2,476.76万 | 1.41%1,344.15万 | -3.51%5,557.15万 | -5.93%4,955.88万 | -25.82%2,553.07万 |
| 财务费用 | 17.55%-58.48万 | -10.27%-37.8万 | 33.19%-10.66万 | 2.57%-92.84万 | 5.55%-70.93万 | 27.04%-34.27万 | 14.40%-15.96万 | 40.16%-95.29万 | 44.32%-75.09万 | 50.35%-46.98万 |
| -利息收入 | 18.71%-61.63万 | -4.20%-39.62万 | 27.03%-11.72万 | 3.84%-98.5万 | 8.28%-75.82万 | 25.23%-38.02万 | 15.34%-16.06万 | 36.04%-102.43万 | 39.25%-82.66万 | 46.55%-50.85万 |
| 研发费用 | 24.77%3,775.48万 | 35.70%2,561.93万 | 44.41%1,264.68万 | 14.06%4,452.74万 | 14.65%3,025.93万 | 16.96%1,887.93万 | 68.52%875.74万 | 11.71%3,903.88万 | 47.33%2,639.3万 | 6.79%1,614.13万 |
| 信用减值损失 | -94.99%-1,221.59万 | -36.92%-373万 | -71.23%-260.9万 | 63.21%-313.17万 | 21.72%-626.49万 | 40.39%-272.43万 | -112.84%-152.37万 | -448.51%-851.29万 | -493.74%-800.29万 | -502.42%-456.99万 |
| 资产减值损失 | -569.30%-1.84万 | -349.88%-2.66万 | -636.69%-6.11万 | 242.07%4.01万 | 127.25%3,922.85 | 518.59%1.07万 | 702.76%1.14万 | 154.10%1.17万 | 25.41%-1.44万 | -228.06%-2,545.35 |
| 非经营性净收益 | ||||||||||
| 公允价值变动净收益 | 96.09%-3.6万 | 106.92%11.61万 | -97.80%1.69万 | 581.26%235.19万 | -332.14%-92.08万 | -262.48%-167.7万 | -44.40%76.62万 | -80.58%34.52万 | -56.32%39.67万 | 46.83%103.22万 |
| 投资净收益 | -82.20%141.81万 | -86.07%100.69万 | -66.53%56.98万 | 15.85%343.61万 | 19.39%796.82万 | 38.08%722.73万 | -31.71%170.25万 | -71.22%296.6万 | -18.96%667.43万 | -4.35%523.42万 |
| -其中:对联营合营企业的投资收益 | -44.87%1,878.92 | -130.75%-2,525.18 | 34,111.33%7,026.74 | 57.04%8,786.09 | -66.92%3,408.35 | 73.15%8,212.93 | -100.61%-20.66 | 1,166.66%5,594.73 | 6,087.19%1.03万 | 242.41%4,743.33 |
| 资产处置收益 | ---- | ---- | ---- | -99.65%482.96 | ---- | ---- | ---- | 34.89%13.63万 | --33.31万 | ---- |
| 其他收益 | 82.75%284.88万 | 69.05%218.06万 | 0.20%34.76万 | -21.19%259.5万 | -40.86%155.88万 | 58.09%128.99万 | -15.97%34.69万 | -27.17%329.27万 | -34.35%263.59万 | -19.65%81.59万 |
| 营业利润 | -143.90%-1,896.3万 | -430.38%-3,687.99万 | -118.24%-349.53万 | -51.99%3,611.88万 | -50.80%4,319.51万 | -59.90%1,116.28万 | -33.18%1,916.23万 | -41.54%7,523.45万 | -19.15%8,778.61万 | -44.42%2,783.47万 |
| 加:营业外收入 | -91.17%6.69万 | -98.11%1.41万 | ---- | 1,455.68%76.13万 | 1,448.53%75.78万 | --74.49万 | --0.1 | -48.55%4.89万 | -48.34%4.89万 | ---- |
| 减:营业外支出 | -47.29%30.91万 | 20.71%28.5万 | -86.03%7,129.16 | -16.03%61.5万 | 7.47%58.64万 | -28.13%23.61万 | 5.22%5.1万 | -73.85%73.25万 | -69.70%54.57万 | -17.56%32.85万 |
| 利润总额 | -144.29%-1,920.52万 | -418.30%-3,715.08万 | -118.33%-350.24万 | -51.36%3,626.51万 | -50.32%4,336.64万 | -57.57%1,167.17万 | -33.25%1,911.13万 | -40.82%7,455.1万 | -18.32%8,728.94万 | -44.74%2,750.62万 |
| 减:所得税费用 | -131.75%-218.47万 | -141.11%-71.52万 | -111.62%-37.71万 | -52.75%641.47万 | -53.94%688.2万 | -58.84%173.95万 | -31.06%324.37万 | -36.91%1,357.66万 | -11.20%1,494.03万 | -41.30%422.62万 |
| 净利润 | -146.65%-1,702.04万 | -466.84%-3,643.56万 | -119.70%-312.54万 | -51.04%2,985.04万 | -49.57%3,648.44万 | -57.34%993.22万 | -33.68%1,586.76万 | -41.63%6,097.44万 | -19.66%7,234.91万 | -45.32%2,328.01万 |
| 持续经营净利润 | -146.65%-1,702.04万 | -466.84%-3,643.56万 | -119.70%-312.54万 | -51.04%2,985.04万 | -49.57%3,648.44万 | -57.34%993.22万 | -33.68%1,586.76万 | -41.63%6,097.44万 | -19.66%7,234.91万 | -45.32%2,328.01万 |
| 减：少数股东损益 | -352.54%-289.58万 | ---192.76万 | ---91.62万 | -1,213.06%-166.82万 | -4,824.00%-63.99万 | ---- | --0 | 97.79%-12.71万 | 99.29%-1.3万 | 99.53%-8,749.91 |
| 归属于母公司所有者的净利润 | -138.05%-1,412.47万 | -447.44%-3,450.8万 | -113.92%-220.92万 | -48.42%3,151.87万 | -48.70%3,712.43万 | -57.35%993.22万 | -33.69%1,586.76万 | -44.55%6,110.14万 | -21.25%7,236.21万 | -47.57%2,328.88万 |
| 每股收益 | ||||||||||
| 基本每股收益 | -133.33%-0.03 | -500.00%-0.08 | -125.00%-0.01 | -46.67%0.08 | -50.00%0.09 | -66.67%0.02 | -33.33%0.04 | -44.44%0.15 | -18.18%0.18 | -45.45%0.06 |
| 稀释每股收益 | -133.33%-0.03 | -500.00%-0.08 | -125.00%-0.01 | -46.67%0.08 | -50.00%0.09 | -66.67%0.02 | -20.00%0.04 | -44.44%0.15 | -18.18%0.18 | -45.45%0.06 |
| 其他综合收益 | ||||||||||
| 综合收益总额 | -146.65%-1,702.04万 | -466.84%-3,643.56万 | -119.70%-312.54万 | -51.04%2,985.04万 | -49.57%3,648.44万 | -57.34%993.22万 | -33.68%1,586.76万 | -41.63%6,097.44万 | -19.66%7,234.91万 | -45.32%2,328.01万 |
| 归属于母公司所有者的综合收益总额 | -138.05%-1,412.47万 | -447.44%-3,450.8万 | -113.92%-220.92万 | -48.42%3,151.87万 | -48.70%3,712.43万 | -57.35%993.22万 | -33.69%1,586.76万 | -44.55%6,110.14万 | -21.25%7,236.21万 | -47.57%2,328.88万 |
| 归属于少数股东的综合收益总额 | -352.54%-289.58万 | ---192.76万 | ---91.62万 | -1,213.06%-166.82万 | -4,824.00%-63.99万 | ---- | --0 | 97.79%-12.71万 | 99.29%-1.3万 | 99.53%-8,749.91 |
| 货币单位 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 |
| 会计准则 | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) |
| 审计意见 | -- | -- | -- | 无保留意见 | -- | -- | -- | 无保留意见 | -- | -- |
| 会计师事务所 | -- | -- | -- | 大华会计师事务所(特殊普通合伙) | -- | -- | -- | 大华会计师事务所(特殊普通合伙) | -- | -- |
FY：Financial Year 年度报告，相当于上市公司向SEC披露的10-K文件。
Q：Quarter 季度报告，相当于上市公司向SEC披露的10-Q文件，其中Q1、Q2、Q3、Q4为单季报，跨度为3个月；Q6、Q9为累计季报，Q6为6个月，Q9为9个月。
分析
目标价预测
暂无数据
热议
沪深
综合热度
股票代码
最新价
涨跌幅
暂无数据